TCGA analysis demonstrated that PCa tissues expressed lower levels of FRMD6 in comparison to normal prostate tissues (Figure S3A) and PCa tissues with adverse pathological features (Gleason ≥ 8, T ≥ 3 and N1) expressed lower levels of FRMD6 (Figure 7A). Here, FRMD6 is linked to posterior cortical atrophy.